longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Li Auto

LI

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI
2026-W37 · 2026-09-07

LI.US Weekly Report · 2026-W37

Executive Summary

Li Auto’s stock declined 3.66% to $11.81, hitting a 52-week low. The latest Q2 earnings revealed widening losses with EPS down 275% year-over-year and revenue declining 10.41%, significantly missing consensus expectations. This contrasts sharply with analyst optimism: 16 out of 26 analysts maintain buy/strong buy ratings with an average target price of $16.03 (36% upside), highlighting a notable disconnect between Wall Street expectations and market sentiment.

Price Action

The stock fell 3.66% this week, closing at $11.81 from $12.37 last Friday. Intraweek volatility remained elevated with a high of $12.73 (Sept 8) and low of $11.62 (Sept 10), representing a 9.54% swing. Trading volume remained steady at ~3.1M shares per day over four trading days, consistent with the 60-day average, showing no unusual concentration. Post-market trading on Sept 11 saw modest recovery to $11.85.

The weekly price action reflects a consistent downtrend following the initial open, with the stock rallying from its low but failing to reclaim the week’s opening level. This pattern suggests sustained selling pressure.

Valuation & Earnings

Valuation: The stock’s price-to-book (PB) ratio stands at 1.29x, an extreme historic low. The valuation snapshot indicates the stock is trading at approximately the 9th percentile of its 5-year range, meaning it has traded above current levels 90% of the time historically. The industry median PB is 0.87x; while the stock carries a premium versus sector average, it is substantially below the company’s historical median.

Earnings Performance: Q2 2026 EPS came in at -$0.2499, improving sequentially from Q1’s -$0.3269 but deteriorating sharply versus Q2 2025’s +$0.1428—a 275% year-over-year decline. Operating revenue of $3.78 billion was down 10.4% YoY but up 14% QoQ from $3.32 billion. Net loss expanded to $251M (vs. $152M profit in Q2 2025), representing a 265% deterioration. Operating margin compressed to -3.8% from +2.9%.

Operating income of -$321M reflects a full operating loss reversal compared to $120M operating profit a year ago. This indicates pressure extends beyond revenue weakness into cost management. Net margin deteriorated from 3.6% to -6.6%.

Consensus Comparison: Earnings revision trackers show recent consensus EPS estimates ranging from -0.066 to +0.024, reflecting wide dispersion among analysts on near-term recovery timing.

Capital Flows

As of Sept 11, capital distribution showed: Large institutional funds recorded modest inflows (7.33 vs. 4.73 outflow ratio), indicating lukewarm institutional participation; medium-sized funds posted net outflows (68.42 inflow vs. 76.19 outflow); retail/small funds showed material net inflows (120.11 vs. 110.04), reflecting retail appetite at depressed prices.

The capital structure reveals a bifurcation: retail buyers stepping in at support levels while institutional and mid-sized participants remain cautious. Small investor accumulation during declining prices suggests some market participants view current levels as attractive.

Analyst Ratings

Among 26 analysts, 8 rate the stock “strong buy,” 8 rate it “buy,” totaling 16 bullish ratings (62% buy/strong buy ratio). Fourteen analysts rate it “hold,” while 3 rate it “reduce.” No sell ratings are present. This consensus skew toward constructive reflects analysts’ confidence in long-term business strategy, though may underweight near-term earnings deterioration.

The consensus target price of $16.03 implies 35.7% upside from current levels. It should be noted that analyst ratings carry inherent lag and may not respond quickly to material earnings misses.

Weekly News Highlights

  1. Li Auto (NASDAQ:LI) Hits New 52-Week Low - What’s Next?
  2. Li Auto Partners with Golf Events for European Market Expansion; Overseas i6 Named “Li 6”
  3. Li Auto Inc. Class A Shares (L87) Receives Buy Rating from CGS International
  4. Li Auto to Launch i9 Flagship Electric SUV on Sept 16, Emphasizing Family Comfort Experience
  5. Li Auto Submits 2026 Mid-Year Report to SEC

The company continues advancing product launches and international expansion this week. The i9 flagship SUV is scheduled for rollout mid-month, while European penetration accelerates through strategic golf event partnerships with the “Li 6” model name now official. These product-level positives create temporal disconnect with the severity of reported earnings deterioration—the market appears more responsive to immediate profitability stress than forward product momentum.

Key Contradictions & Observations

The central tension this week is: Historically cheap valuation + constructive analyst consensus versus deteriorating earnings + persistent price decline.

Breaking this down:

  • PB at the 9th percentile of 5-year history with 36% average analyst upside should theoretically attract value buyers, yet the stock hit a 52-week low this week post-earnings. This suggests the pace of earnings deterioration outpaces consensus repair timelines.
  • Analyst buy/strong buy rating at 62% would typically be bullish by sector standards, but likely reflects confidence in long-term business transformation (new vehicle launches, international expansion) rather than near-term profit recovery. The 275% EPS decline YoY suggests earnings revisions may lag reality.
  • Retail capital inflows amid falling prices indicate small-account believers at support levels, yet this “capitulation” signal requires stabilizing fundamentals to confirm a meaningful inflection.

Critical Risk: If Q3-Q4 results disappoint further or guidance is cut again, analyst target prices risk material downward revision, and the current valuation floor may prove unreliable without earnings stabilization evidence.

This content is generated using Longbridge Skill and CLI with open data from the Developers platform. For reference only and does not constitute investment advice. Investments carry risks; please make decisions with caution.